Vimseltinib is a kinase inhibitor used as a pharmaceutical raw material. It acts as a macrophage colony-stimulating factor receptor antagonist and is investigated for applications in oncology research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1628606-05-2
Fezolinetant
pharmaceutical raw material
Biafungin acetate
pharmaceutical raw material
Gestrinone
pharmaceutical raw material
Cholane-3,7,24-triol, 6-ethyl-, (3α,5β,6β,7β)-
pharmaceutical raw material
3-methyl-5-[6-methyl-5-[[2-(1-methylpyrazol-4-yl)-4-pyridinyl]oxy]-2-pyridinyl]-2-(propan-2-ylamino)pyrimidin-4-one
TVGAHWWPABTBCX-UHFFFAOYSA-N
CC1=C(C=CC(=N1)C2=CN=C(N(C2=O)C)NC(C)C)OC3=CC(=NC=C3)C4=CN(N=C4)C